FDA suspends ban on Juul vaping products

The Food and Drug Administration announced on Tuesday that it will suspend its ban on the sale of Juul vaping products.

The agency said the administrative stay of its marketing denial order against Juul was a result of “scientific issues” that need additional review. In June, the FDA ordered the vaping company to pull its devices and nicotine liquid pods off shelves, determining that Juul had not shown enough evidence that its products do not hurt public health.

FDA ORDERS JUUL VAPES OFF SHELVES

“On July 5, 2022, FDA administratively stayed the marketing denial order. The agency has determined that there are scientific issues unique to the JUUL application that warrant additional review,” the FDA said in a message posted on Twitter.

“This administrative stay temporarily suspends the marketing denial order during the additional review but does not rescind it,” the agency noted, adding that the stay “does not constitute authorization to market, sell, or ship JUUL products.”

The U.S. Court of Appeals for the District of Colombia Circuit granted Juul a temporary stay one day after the FDA ordered the ban on its vaping products. Juul had separately asked the FDA to stay its own order pending an appeal.

Juul alleges that the FDA mishandled its application by overlooking more than 6,000 pages of data submitted to the agency. In court documents, the San Francisco-based company also accused the FDA of being influenced by political pressure rather than science when it implemented the ban.

Juul e-cigarettes have drawn scrutiny for their role in igniting a teenage vaping epidemic. Congressional critics of the company, including Sen. Dick Durbin (D-IL) and Rep. Raja Krishnamoorthi (D-IL), have accused Juul of deliberately marketing its products toward youths.

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

The teenage vaping rate dropped in 2021 to 11.3% of high school students, down from 19.6% in 2020 and 27.5% in 2019, according to data from the Centers for Disease Control and Prevention.

The Washington Examiner reached out to Juul for comment.

Related Content